SCHOTT PHARMA AG & CO. KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.02 EUR | -4.34% |
|
-5.85% | +10.18% |
| Apr. 22 | SCHOTT PHARMA : Jefferies remains Neutral | ZD |
| Apr. 11 | Gerresheimer very weak - Certain uncertainties about outlook | DP |
Evolution of the average Target Price on SCHOTT Pharma AG & Co. KGaA
Price target over the last 5 years
History of analyst recommendation changes
4903d57cd173527ac0a608da303038d.HrTucpegC2JxU7hmZF6Nemyll5Zs9__8GkYRSt3-AhY.a_imIKPrYy4iMvsWVBjKSAj6wMwWxpuNbQJCDq6QaHAs358D2PVIIzlq8Q~6488f145784b0c0d98c8c15750c9e0ac
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
37.02
EUR
Average target price
38.67
EUR
Spread / Average Target
+4.46%
High Price Target
45
EUR
Spread / Highest target
+21.56%
Low Price Target
30
EUR
Spread / Lowest Target
-18.96%
Consensus detail
Consensus revision (last 18 months)
Analysts covering SCHOTT Pharma AG & Co. KGaA
| JEFFERIES | James Vane-Tempest |
| BERENBERG | Victoria Lambert |
| DEUTSCHE BANK RESEARCH | Falko Friedrichs |
| BARCLAYS | Gaurav Jain |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 1SXP Stock
- Consensus SCHOTT Pharma AG & Co. KGaA